Covered Call Analyzer Conservative "STOCKS-TO-CONSIDER"     

  for October, 2003                                                                                   Close Window

Company Name

Stock Symbol

Stock Price

# of shares

Total Cost*

 Option Symbol

 Nov Option Price

Income from sale*

Strike Price

Projected return if Called after one month*

Actual 

$ 

return*

Actual 

% 

Return*
USG Corp. USG $17.47 500 $8,775 USGKE $0.60 $280 25 38% ($305) -3%
Comments:

Not called. Sold Dec17.5 at 0.55. Not Called. Sold all shares at $15.79 to close out position.
USG Corp. USG $17.47 500 $8,775 USGKX $0.95 $455 22.5 28% ($130) -1%
Comments:

Not called. Sold Dec17.5 at 0.55. Not Called. Sold all shares at $15.79 to close out position.

American Pharm.

APPX

$27.37

300

$8,231

AQOKG

$0.65

$175

35

24%

+$2,124

+26%

Comments:

Not called. Sold Dec30 at 4.00. Called.
USG Corp. USG $17.47 500 $8,755 USGKD $1.60 $780 20 19% +$195 +2%
Comments:

Not called. Sold Dec17.5 at 0.55. Not Called. Sold all shares at $15.79 to close out position.
United Online, Inc. UNTD $25.51 300 $7,673 QABKF $1.10 $310 30 18% ($925) -12%
Comments:

Exercised get-out price at $21.68 after buying back calls at 0.22.

American Pharm.

APPX

$27.37 300 $8,231 AQOKF $1.80 $520 30 13% +$1,289 +13%
Comments:

Called.

CREE, Inc.

CREE

$18.05 500 $9,045 CVOKD $0.75 $355 20 12% +$310 +3%
Comments:

Not called. Sold Dec20 at 0.60. Not Called. Sold all shares at $17.40 to close out position.

LaBranche & Co, Inc.

 LAB $11.15 800 $8,940 LABKV $0.30 $220 12.5 12% ($1,192) -13%
Comments:

Exercised get-out price at $9.48 after buying back calls at 0.07.

AMDOCS LTD

 DOX $20.16 400 $8,044 DOXKX $0.45 $160 22.5 11% +$1,076 +11%
Comments:

Called.

Enzon Pharm.

ENZN

 $11.28 800 $9,044 QYZKV $0.30 $220 12.5 11% +$384 +4%
Comments:

Not called. Sold Dec12.5 at 0.35. Not Called. Sold all shares at $11.16 to close out position.

All positions closed out with portfolio value up +$2,827.

*After the effect of all commissions.

The stocks listed above are for illustrative and educational purposes only and should not be construed as an endorsement, recommendation, or solicitation to buy or sell any particular security.

top